Table 1.
Susceptibility Profile (MIC) | |||
---|---|---|---|
Antimicrobial | Patient 1 | Patient 2 | Patient 3 |
Piperacillin–tazobactam | R | R (64/4) | R (64/4) |
Ceftazidime | I | R (16) | R (>16) |
Ceftazidime–avibactam | S | S (8/4) | S (4/4) |
Cefepime | I | R (>8) | R (>8) |
Ceftolozane–tazobactam | R | R (>4/4) | R (>4/4) |
Imipenem | R | R (>8) | R (>8) |
Meropenem | R | R (>16) | R (>16) |
Meropenem–vaborbactam | R | R (>8/8) | R (>8/8) |
Aztreonam | I | R (>16) | I (8) |
Amikacin | R | R (>16) | S (16) |
Tobramycin | R | R (>4) | S (≤1) |
Ciprofloxacin | R | R (>1) | I (0.25) |
Colistin | N/A | S (1) | S (2) |
S, susceptible; I, intermediate; R, resistant; N/A, not available.